← Back to Search

Telemedicine Assessments for Autism

N/A
Recruiting
Led By Zachary Warren, Ph.D.
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 years or older
Child between 18 and 42 months of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and six-month follow-up
Awards & highlights

Summary

This trial will compare the use of a telemedicine tool to assess for autism symptoms in toddlers with gold standard, in-person ASD assessments.

Who is the study for?
This trial is for parents or guardians of toddlers aged 18-42 months who may have autism. Participants must be over 18, speak English well enough to follow the study procedures, live within a 3-hour drive from the study sites, and have access to technology with internet and audio-visual capabilities for tele-assessment.
What is being tested?
The study is testing a telemedicine tool called TELE-ASD-PEDS (TAP) designed for assessing autism symptoms in toddlers at home. It compares the effectiveness of TAP assessments done remotely with traditional in-person evaluations.
What are the potential side effects?
Since this trial involves assessment tools rather than medical treatments, there are no direct physical side effects. However, participants might experience inconvenience or stress related to using new technology or due to the time commitment required.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My child is between 18 and 42 months old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and six-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and six-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Diagnostic accuracy of the TAP
Validity of the TAP
Secondary study objectives
Child service access and utilization
Family empowerment
Family perceptions of tele-assessment
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-assessment + in-person assessmentExperimental Treatment1 Intervention
Participants in this group will receive a tele-assessment using the TAP and will attend a traditional, in-person evaluation for autism spectrum disorder in a clinic setting.
Group II: Tele-assessment onlyActive Control1 Intervention
Participants in this group will receive a tele-assessment using the TAP, followed by a second, shorter tele-assessment.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,869 Previous Clinical Trials
2,776,816 Total Patients Enrolled
83 Trials studying Autism Spectrum Disorder
39,877 Patients Enrolled for Autism Spectrum Disorder
Vanderbilt University Medical CenterLead Sponsor
888 Previous Clinical Trials
934,214 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
1,689 Patients Enrolled for Autism Spectrum Disorder
Zachary Warren, Ph.D.Principal InvestigatorVanderbilt University Medical Center

Media Library

Autism Spectrum Disorder Research Study Groups: Tele-assessment + in-person assessment, Tele-assessment only
~225 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top